Updates in the Systemic Therapy Options for Clear Cell and Non-Clear Cell Renal Cell Carcinoma

被引：0

作者：

Spiess, Philippe E. ^{[1
]}

Johnstone, Peter A. S. ^{[1
]}

Jonasch, Eric ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 1374, Houston, TX 77030 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2023年 / 21卷 / 5.5期

关键词：

D O I：

10.6004/jnccn.2023.5020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non-clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.

引用

页数：4

共 50 条

[21] Targeted therapies and the treatment of non-clear cell renal cell carcinoma
Bellmunt, J.
Dutcher, J.
ANNALS OF ONCOLOGY, 2013, 24 (07) : 1730 - 1740
[22] Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
Heng, Daniel Y. C.
Bukowski, Ronald M.
ONCOLOGY REVIEWS, 2007, 1 (03) : 170 - 176
[23] Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma
Han, Seung Hun
Camp, Sabrina Y.
Chu, Hoyin
Collins, Ryan
Gillani, Riaz
Park, Jihye
Bakouny, Ziad
Ricker, Cora A.
Reardon, Brendan
Moore, Nicholas
Kofman, Eric
Labaki, Chris
Braun, David
Choueiri, Toni K.
AlDubayan, Saud H.
Van Allen, Eliezer M.
EUROPEAN UROLOGY OPEN SCIENCE, 2024, 62 : 107 - 122
[24] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
Ismail Selvi
Umut Demirci
Nazan Bozdogan
Halil Basar
International Urology and Nephrology, 2021, 53 : 1135 - 1138
[25] Therapy for Non-Clear Cell Histologies in Renal Cancer
Bitting, Rhonda L.
Madden, John
Armstrong, Andrew J.
CURRENT CLINICAL PHARMACOLOGY, 2011, 6 (03): : 169 - 180
[26] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
Selvi, Ismail
Demirci, Umut
Bozdogan, Nazan
Basar, Halil
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
[27] Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options
Wilson, Nathaniel R.
Acikgoz, Yusuf
Hasanov, Elshad
INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (06) : 947 - 961
[28] Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma
Armstrong, Andrew J.
Nixon, Andrew B.
Carmack, Andrea
Yang, Qian
Eisen, Tim
Stadler, Walter M.
Jones, Robert J.
Garcia, Jorge A.
Vaishampayan, Ulka N.
Picus, Joel
Hawkins, Robert E.
Hainsworth, John D.
Kollmannsberger, Christian K.
Logan, Theodore F.
Puzanov, Igor
Pickering, Lisa M.
Ryan, Christopher W.
Protheroe, Andrew
George, Daniel J.
Halabi, Susan
CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3317 - 3328
[29] Update on systemic therapy for clear cell renal cell carcinoma
Josef Mühlmann
memo - Magazine of European Medical Oncology, 2023, 16 : 38 - 41
[30] Update on systemic therapy for clear cell renal cell carcinoma
Muehlmann, Josef
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 38 - 41

← 1 2 3 4 5 →